Your browser doesn't support javascript.
loading
Therapeutic targeting of GSK3ß enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C.
Jiang, Yongfang; Bao, Hui; Ge, Yan; Tang, Wei; Cheng, Du; Luo, Kaizhong; Gong, Guozhong; Gong, Rujun.
Affiliation
  • Jiang Y; Liver Diseases Research Center, The Second Xiangya Hospital, Central South University, Changsha, China Department of Medicine, Rhode Island Hospital, Brown University School of Medicine, Providence, Rhode Island, USA.
  • Bao H; Department of Medicine, Rhode Island Hospital, Brown University School of Medicine, Providence, Rhode Island, USA.
  • Ge Y; Department of Medicine, Rhode Island Hospital, Brown University School of Medicine, Providence, Rhode Island, USA.
  • Tang W; Liver Diseases Research Center, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Cheng D; Liver Diseases Research Center, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Luo K; Liver Diseases Research Center, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Gong G; Liver Diseases Research Center, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Gong R; Department of Medicine, Rhode Island Hospital, Brown University School of Medicine, Providence, Rhode Island, USA.
Gut ; 64(1): 168-79, 2015 Jan.
Article in En | MEDLINE | ID: mdl-24811996

Full text: 1 Database: MEDLINE Main subject: Hepatitis C, Chronic / Cytoprotection / Hepatocytes / Glycogen Synthase Kinase 3 / NF-E2-Related Factor 2 Limits: Humans Language: En Journal: Gut Year: 2015 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Hepatitis C, Chronic / Cytoprotection / Hepatocytes / Glycogen Synthase Kinase 3 / NF-E2-Related Factor 2 Limits: Humans Language: En Journal: Gut Year: 2015 Type: Article Affiliation country: United States